Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/24
End: 05/30/26
Due: 05/30/27
Phase: N/A
Priority: Normal
Start: 07/31/23
End: 07/31/24
Due: 07/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage | NCT06402968 | Zeenat Qureshi Stroke Institute | user2@example.com | None | 2024-06-01 | 2026-05-30 | 2027-05-30 | - | - | 2025-07-14 |
| Endovascular Stroke Treatment And Reteplase Protocol | NCT05900674 | Zeenat Qureshi Stroke Institute | user2@example.com | None | 2023-07-31 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |